- Home
- Publications
- Publication Search
- Publication Details
Title
Immunology and Immunotherapy of Chronic Myeloid Leukemia
Authors
Keywords
CML, Immunology, Tyrosine Kinase Inhibitors, Tumor Antigens, Vaccine, Stem Cell, NK-Cell
Journal
Current Hematologic Malignancy Reports
Volume 9, Issue 1, Pages 17-23
Publisher
Springer Nature
Online
2014-01-04
DOI
10.1007/s11899-013-0190-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective killing of candidate AML stem cells by antibody targeting of IL1RAP
- (2013) M. Askmyr et al. BLOOD
- Tyrosine kinase inhibitors impair B-cell immune responses in CML through off-target inhibition of kinases important for cell signaling
- (2013) H. de Lavallade et al. BLOOD
- Safety and efficacy of imatinib cessation for CML patients with stable undetectable minimal residual disease: results from the TWISTER study
- (2013) D. M. Ross et al. BLOOD
- Sustained upregulation of effector natural killer cells in chronic myeloid leukemia after discontinuation of imatinib
- (2013) Izuru Mizoguchi et al. CANCER SCIENCE
- CTLA-4 and PD-1/PD-L1 Blockade: New Immunotherapeutic Modalities with Durable Clinical Benefit in Melanoma Patients
- (2013) P. A. Ott et al. CLINICAL CANCER RESEARCH
- Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients
- (2013) Giorgio La Nasa et al. EXPERIMENTAL HEMATOLOGY
- Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
- (2013) S Mustjoki et al. LEUKEMIA
- Induction of sustained deep molecular response in a patient with chronic-phase T315I-mutated chronic myeloid leukemia with interferon-α monotherapy
- (2013) Mette Ilander et al. LEUKEMIA & LYMPHOMA
- Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene
- (2013) Monica Casucci et al. MOLECULAR THERAPY
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- Nivolumab plus Ipilimumab in Advanced Melanoma
- (2013) Jedd D. Wolchok et al. NEW ENGLAND JOURNAL OF MEDICINE
- Increased Level of Myeloid-Derived Suppressor Cells, Programmed Death Receptor Ligand 1/Programmed Death Receptor 1, and Soluble CD25 in Sokal High Risk Chronic Myeloid Leukemia
- (2013) Lisa Christiansson et al. PLoS One
- Dasatinib may overcome the negative prognostic impact of KIR2DS1 in newly diagnosed patients with chronic myeloid leukemia
- (2012) S. Ali et al. BLOOD
- Mutated BCR-ABL Generates Immunogenic T-cell Epitopes in CML Patients
- (2012) A. Cai et al. CLINICAL CANCER RESEARCH
- Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients
- (2012) Alexis Rossignol et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Killer-cell immunoglobulin-like receptor gene profile predicts good molecular response to dasatinib therapy in chronic myeloid leukemia
- (2012) Anna Kreutzman et al. EXPERIMENTAL HEMATOLOGY
- Direct effect of dasatinib on proliferation and cytotoxicity of natural killer cells inin vitrostudy
- (2012) Takayoshi Uchiyama et al. HEMATOLOGICAL ONCOLOGY
- Enhancement of natural killer cell effector functions against selected lymphoma and leukemia cell lines by dasatinib
- (2012) Nicole Hassold et al. INTERNATIONAL JOURNAL OF CANCER
- Successful treatment of a chronic-phase T-315I-mutated chronic myelogenous leukemia patient with a combination of imatinib and interferon-alfa
- (2012) Hidehiro Itonaga et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rapid and sustained increase of large granular lymphocytes and rare cytomegalovirus reactivation during dasatinib treatment in chronic myelogenous leukemia patients
- (2012) Hideo Tanaka et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial
- (2012) Jorge E. Cortes et al. JOURNAL OF CLINICAL ONCOLOGY
- Rapid mobilization of cytotoxic lymphocytes induced by dasatinib therapy
- (2012) S Mustjoki et al. LEUKEMIA
- Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib
- (2012) Yoshiki Hayashi et al. LEUKEMIA & LYMPHOMA
- Combination of pegylated IFN- 2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
- (2011) B. Simonsson et al. BLOOD
- Quantitative and functional analyses of CD4+CD25+FoxP3+ regulatory T cells in chronic phase chronic myeloid leukaemia patients at diagnosis and on imatinib mesylate
- (2011) Emmanuel Bachy et al. BRITISH JOURNAL OF HAEMATOLOGY
- Increased natural killer cells and decreased CD3+CD8+CD62L+ T cells in CML patients who sustained complete molecular remission after discontinuation of imatinib
- (2011) Kazuma Ohyashiki et al. BRITISH JOURNAL OF HAEMATOLOGY
- Antigens in chronic myeloid leukemia: implications for vaccine development
- (2011) Michal Šmahel CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dasatinib Combined with Interferon-alfa Induces a Complete Cytogenetic Response and Major Molecular Response in a Patient with Chronic Myelogenous Leukemia Harboring the T315I BCR-ABL1 Mutation
- (2011) A. Megan Cornelison et al. Clinical Lymphoma Myeloma & Leukemia
- Expression and distribution of PPP2R5C gene in leukemia
- (2011) Haitao Zheng et al. Journal of Hematology & Oncology
- KIR2DS1 genotype predicts for complete cytogenetic response and survival in newly diagnosed chronic myeloid leukemia patients treated with imatinib
- (2011) D Marin et al. LEUKEMIA
- NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR–ABL-positive mice
- (2011) C I-U Chen et al. LEUKEMIA
- Expansion of highly differentiated CD8+ T-cells or NK-cells in patients treated with dasatinib is associated with cytomegalovirus reactivation
- (2011) A Kreutzman et al. LEUKEMIA
- Chronic Myeloid Leukemia Patients in Prolonged Remission following Interferon-α Monotherapy Have Distinct Cytokine and Oligoclonal Lymphocyte Profile
- (2011) Anna Kreutzman et al. PLoS One
- Natural Killer Cell Mediated Missing-Self Recognition Can Protect Mice from Primary Chronic Myeloid Leukemia In Vivo
- (2011) Mika Kijima et al. PLoS One
- Characterization of chronic myeloid leukemia stem cells
- (2010) Jonathan M. Gerber et al. AMERICAN JOURNAL OF HEMATOLOGY
- Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia
- (2010) P. G. Maslak et al. BLOOD
- Mono/oligoclonal T and NK cells are common in chronic myeloid leukemia patients at diagnosis and expand during dasatinib therapy
- (2010) A. Kreutzman et al. BLOOD
- Immunoprofiling of patients with chronic myeloid leukemia at diagnosis and during tyrosine kinase inhibitor therapy
- (2010) Peter Rohon et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- The BCR/ABL-inhibitors imatinib, nilotinib and dasatinib differentially affect NK cell reactivity
- (2010) Julia Salih et al. INTERNATIONAL JOURNAL OF CANCER
- Sustained Molecular Response With Interferon Alfa Maintenance After Induction Therapy With Imatinib Plus Interferon Alfa in Patients With Chronic Myeloid Leukemia
- (2010) Andreas Burchert et al. JOURNAL OF CLINICAL ONCOLOGY
- Discontinuation of imatinib in patients with chronic myeloid leukaemia who have maintained complete molecular remission for at least 2 years: the prospective, multicentre Stop Imatinib (STIM) trial
- (2010) François-Xavier Mahon et al. LANCET ONCOLOGY
- Imatinib plus Peginterferon Alfa-2a in Chronic Myeloid Leukemia
- (2010) Claude Preudhomme et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
- (2010) Hagop Kantarjian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia
- (2010) Giuseppe Saglio et al. NEW ENGLAND JOURNAL OF MEDICINE
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Isolation and killing of candidate chronic myeloid leukemia stem cells by antibody targeting of IL-1 receptor accessory protein
- (2010) M. Jaras et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Molecular and functional analysis of the stem cell compartment of chronic myelogenous leukemia reveals the presence of a CD34- cell population with intrinsic resistance to imatinib
- (2009) R. M. Lemoli et al. BLOOD
- A clinical and immunologic phase 2 trial of Wilms tumor gene product 1 (WT1) peptide vaccination in patients with AML and MDS
- (2009) U. Keilholz et al. BLOOD
- AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant and Overcomes Mutation-Based Resistance
- (2009) Thomas O'Hare et al. CANCER CELL
- Clonal expansion of T/NK-cells during tyrosine kinase inhibitor dasatinib therapy
- (2009) S Mustjoki et al. LEUKEMIA
- Aurora-A kinase: a novel target of cellular immunotherapy for leukemia
- (2008) T. Ochi et al. BLOOD
- Profound Inhibition of Antigen-Specific T-Cell Effector Functions by Dasatinib
- (2008) R. Weichsel et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now